Allelica supports doctors and patients to prevent cardiovascular events.
Allelica identifies “invisible” high-risk patients, those with normal LDL but genetic risk equivalent to familial hypercholesterolemia. Our one-time, non-invasive test uncovers risk missed by traditional assessments, empowering doctors to act earlier with targeted LDL-lowering and lifestyle interventions, preventing heart attacks and improving outcomes for millions previously overlooked.
Want to be sure you or your patients don’t have a hidden, dangerous risk factor?
Dr. Rigved Tadwalkar, Pacific Heart Institute, on using PRS testing.
Polygenic Risk Score (PRS) testing analyzes your DNA to estimate genetic risk for heart disease. Using thousands of genetic markers, PRS provides early insight so doctors and patients can act before symptoms appear.